NCT02932462View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

September 29, 2017

Conditions
Scalp Psoriasis
Interventions
DRUG

DSXS

topical product

DRUG

Placebo

topical product

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02932462 - Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis | Biotech Hunter | Biotech Hunter